Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
出版年份 2021 全文链接
标题
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages JCO.20.03286
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2021-04-08
DOI
10.1200/jco.20.03286
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging
- (2020) Cordula Maria Wolf et al. Frontiers in Pediatrics
- Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
- (2020) Andrea Gallamini et al. JOURNAL OF CLINICAL ONCOLOGY
- Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group
- (2019) Kara M. Kelly et al. BRITISH JOURNAL OF HAEMATOLOGY
- Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
- (2018) Joseph M. Connors et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pediatric Hodgkin Lymphoma
- (2015) Christine Mauz-Körholz et al. JOURNAL OF CLINICAL ONCOLOGY
- Group Sequential Design for Randomized Phase III Trials under the Weibull Model
- (2014) Jianrong Wu et al. Journal of Biopharmaceutical Statistics
- Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate-Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group Study AHOD0031
- (2014) Debra L. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Children and Adolescents With Hodgkin Lymphoma Without Radiotherapy for Patients in Complete Remission After Chemotherapy: Final Results of the Multinational Trial GPOH-HD95
- (2013) Wolfgang Dörffel et al. JOURNAL OF CLINICAL ONCOLOGY
- Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy and Survival Among Children With Favorable-Risk Hodgkin Lymphoma
- (2012) Monika L. Metzger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Impact of Drug Shortages on Children with Cancer — The Example of Mechlorethamine
- (2012) Monika L. Metzger et al. NEW ENGLAND JOURNAL OF MEDICINE
- BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group
- (2010) K. M. Kelly et al. BLOOD
- Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study
- (2010) Christine Mauz-Körholz et al. JOURNAL OF CLINICAL ONCOLOGY
- A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425
- (2009) C. L. Schwartz et al. BLOOD
- The Dimensions of Pain Quality: Factor Analysis of the Pain Quality Assessment Scale
- (2008) Timothy W. Victor et al. CLINICAL JOURNAL OF PAIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now